Headache impact study for Libbs employees
Part of Brain & nervous system, Pain clinical trials.
This trial looks at how headaches affect employees at Libbs Pharmaceutical. It uses health data from the Dr. Cefaleia app to understand the burden of headaches at work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an employee of Libbs Pharmaceutical
- You must have taken part in the Dr. Cefaleia app assistance program
- You must have given permission to use your data from the app
- You must have fully completed the questionnaires in the app
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a headache diary can help people with migraine track their symptoms and improve their care.
This trial tests a mobile app called Health enSuite Migraine to help manage migraines. You'll track your headaches daily for a month, then use the app to see if it reduces your migraine days.
This study tests a smartphone app called RELAXaHEAD that teaches relaxation techniques to help people with migraine. If you have 4–29 headache days per month and haven't tried relaxation therapy for headaches recently, this app might help reduce your symptoms.
This study tests whether a specific diet change can help reduce migraine frequency. Participants will follow a structured diet plan for several weeks to see if it leads to fewer headache days.
This study uses a smartphone app or device to track your body signals and predict when a migraine attack is about to start. It is designed for people with frequent (10–14 days per month) migraines.
This trial studies a mind-body balance approach to help reduce symptoms and disability from pediatric migraine. You may join if your child has migraine headaches and can follow study routines, including keeping a headache diary.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.